Register for streaming realtime charts, analysis tools, and prices.
BioTech
New MSRA Treatment Could Bring Billions In Revenues
Mar 04 2013 @ 13:12
Trius Therapeutics (TSRX) Trius is expecting top-line data from its 2nd Phase III trial of Tedizolid (TR-701...
Will 2013 Be The Year For MultiCell Technologies?
Feb 25 2013 @ 14:05
MultiCell Technologies, Inc. (MCET) is a biopharmaceutical company, engaged in the research, development, and...
Cellceutix Cancer Treatment On Track
Feb 22 2013 @ 23:40
Cellceutix (CTIX:OTC) is a clinical stage biotechnology company focused on discovering small molecule drugs for hard...
Cyclacel Pharmaceuticals offers a nice catalyst trade opportunity
Feb 20 2013 @ 08:05
Cyclacel Pharmaceuticals (NASDAQ: CYCC) is expecting safety data and full myelodysplastic syndromes (MDS) data by...
DARA: Catalyst BioTech Break-Out Trade
Feb 15 2013 @ 08:24
DARA Biosciences (NASDAQ: DARA) is expecting to hear soon on the status of its Orphan Drug application submitted to...
Unusual Option Volume For February 13, 2013
Feb 13 2013 @ 14:35
Tracking unusual option volume can be a great way for investors to follow the smart money. If a particular option...
Why And How To Play AMRN
Feb 06 2013 @ 08:11
One of the most heavily followed stocks in the healthcare industry is Amarin (NASDAQ: AMRN), which recently...
Top 2 Stocks with Unusual Call Activities on Tuesday: VIVUS and Merck
Feb 05 2013 @ 22:00
Tuesday’s market sentiment was driven by extreme greed with Fear & Greed Index at 85, which had increased from...
January's Top ETF Performers include Healthcare & Energy
Feb 01 2013 @ 15:18
Across twenty five of the most widely traded market, sector and industry ETFs, healthcare and energy were among...
Stocks Losing Favor with Analysts: WFC, ARMH, AXP, IBM, KBR
Jan 23 2013 @ 07:39
Wells Fargo & Co. (NYSE:WFC): The banking stock has been downgraded from Overweight to Neutral by Atlantic...
